September 9, 2019

9/11 World Trade Center Exposure Linked To Heart Disease Among New York City Firefighters

A new study of New York City firefighters has found that exposure to 9/11 World Trade Center dust is associated with a significantly increased long-term risk of cardiovascular disease.
September 6, 2019

Turmeric May Help With Asthma Control In Children

Powdered turmeric may help with asthma control in children, suggests a randomized, double-blind, placebo-controlled, phase II clinical trial from Brazil.
September 5, 2019

Hundreds Of Thousands Of People In England Addicted To Prescription Drugs

Hundreds of thousands of people in England are believed to be addicted to prescription drugs. A recent review looked at the use of strong painkillers, antidepressants and sleeping tablets, used by a quarter of adults in England every year.
September 4, 2019

UK Teenager Loses Sight After Living On Diet Of Potato Chips And French Fries

Experts are warning about the dangers of "fussy eating" after a 17-year-old teenager in the UK suffered irreparable sight loss after living on a diet of potato chips and French fries.
September 3, 2019

Los Angeles Times Publishes Opinion Article Criticizing Pharma Industry

The Los Angeles Times recently published a critical opinion article with the headline: Legal judgements against big pharma aren’t enough – Consumers need to change their drug habits.
September 2, 2019

Aspirin Should Not Be Recommended For Healthy People Aged Over 70

A new trial has found that low-dose aspirin does not prolong disability-free survival of healthy people aged over 70, even in those at the highest risk of cardiovascular disease.
August 30, 2019

Breast Cancer: Menopausal Hormone Replacement Therapy Risks ‘Bigger Than Thought’

The increased risk of breast cancer from menopausal hormone replacement therapy lasts more than a decade after treatment stops, a major report suggests.
August 29, 2019

Johnson & Johnson Court Verdict Sends Opioid Makers A Billion-Dollar Warning

The US pharmaceutical industry faces tens of billions of dollars in potential damage payments for fueling the opioid addiction crisis after Oklahoma won a $572 million judgment against drugmaker Johnson & Johnson.